US Patent 7982016 Antigen binding proteins capable of binding thymic stromal lymphopoietin
Patent 7982016 was granted and assigned to Amgen on July, 2011 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7982016 Antigen binding proteins capable of binding thymic stromal lymphopoietin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.